Efforts to prevent, treat cervical cancer increasing in Africa

NewsGuard 100/100 Score

The Guardian's "Poverty Matters Blog" examines efforts to prevent and treat cervical cancer in sub-Saharan Africa, where "cervical cancer kills large numbers of women, many of whom are never diagnosed because local hospitals do not recognize the disease until it is too late." However, "[a] very simple and cheap form of screening has begun to be introduced -- and now there is the possibility of a vaccination program against the sexually transmitted human papilloma virus (HPV) that causes most cervical cancers," the blog writes, noting a recent announcement by the GAVI Alliance that it plans to fund HPV immunization programs in several countries. According to the blog, "15 countries [are] asking to be considered," and "Uganda and Rwanda have already been approved, although some 'clarifications' are required from the governments on how their programs will run." The blog continues, "No one believes it will be easy to introduce the HPV vaccination in Africa, and there may be problems," including issues with efficacy and cost (Boseley, 12/14).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis